These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19663539)

  • 1. Pharmaceutical metabolites in the environment: analytical challenges and ecological risks.
    Celiz MD; Tso J; Aga DS
    Environ Toxicol Chem; 2009 Dec; 28(12):2473-84. PubMed ID: 19663539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achievements and future trends in the analysis of emerging organic contaminants in environmental samples by mass spectrometry and bioanalytical techniques.
    Farré M; Kantiani L; Petrovic M; Pérez S; Barceló D
    J Chromatogr A; 2012 Oct; 1259():86-99. PubMed ID: 22877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from more than two decades of research on emerging contaminants in the environment.
    Noguera-Oviedo K; Aga DS
    J Hazard Mater; 2016 Oct; 316():242-51. PubMed ID: 27241399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
    Klecka G; Persoon C; Currie R
    Rev Environ Contam Toxicol; 2010; 207():1-93. PubMed ID: 20652664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International scientists' priorities for research on pharmaceutical and personal care products in the environment.
    Rudd MA; Ankley GT; Boxall AB; Brooks BW
    Integr Environ Assess Manag; 2014 Oct; 10(4):576-87. PubMed ID: 24954797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective LC-QTOF-MS analysis searching for pharmaceutical metabolites in urban wastewater.
    Hernández F; Ibáñez M; Gracia-Lor E; Sancho JV
    J Sep Sci; 2011 Dec; 34(24):3517-26. PubMed ID: 21954029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging pollutants in the environment: present and future challenges in biomonitoring, ecological risks and bioremediation.
    Gavrilescu M; Demnerová K; Aamand J; Agathos S; Fava F
    N Biotechnol; 2015 Jan; 32(1):147-56. PubMed ID: 24462777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioaccumulation and analytics of pharmaceutical residues in the environment: A review.
    Puckowski A; Mioduszewska K; Łukaszewicz P; Borecka M; Caban M; Maszkowska J; Stepnowski P
    J Pharm Biomed Anal; 2016 Aug; 127():232-55. PubMed ID: 26968887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment for ecotoxicity of pharmaceuticals--an emerging issue.
    Kar S; Roy K
    Expert Opin Drug Saf; 2012 Mar; 11(2):235-74. PubMed ID: 22166011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selected analytical challenges in the determination of pharmaceuticals in drinking/marine waters and soil/sediment samples.
    Białk-Bielińska A; Kumirska J; Borecka M; Caban M; Paszkiewicz M; Pazdro K; Stepnowski P
    J Pharm Biomed Anal; 2016 Mar; 121():271-296. PubMed ID: 26818066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of human and veterinary drugs' fate in environmental solid samples--analytical problems.
    Wilga J; Kot-Wasik A; Namieśnik J
    J Chromatogr Sci; 2008 Aug; 46(7):601-8. PubMed ID: 18718135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry.
    Grabic R; Fick J; Lindberg RH; Fedorova G; Tysklind M
    Talanta; 2012 Oct; 100():183-95. PubMed ID: 23141327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.
    Huerta B; Rodríguez-Mozaz S; Barceló D
    Anal Bioanal Chem; 2012 Nov; 404(9):2611-24. PubMed ID: 22678760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research.
    Fatta-Kassinos D; Meric S; Nikolaou A
    Anal Bioanal Chem; 2011 Jan; 399(1):251-75. PubMed ID: 21063687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent trends in the liquid chromatography-mass spectrometry analysis of organic contaminants in environmental samples.
    Petrovic M; Farré M; de Alda ML; Perez S; Postigo C; Köck M; Radjenovic J; Gros M; Barcelo D
    J Chromatogr A; 2010 Jun; 1217(25):4004-17. PubMed ID: 20334864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment.
    Cooper ER; Siewicki TC; Phillips K
    Sci Total Environ; 2008 Jul; 398(1-3):26-33. PubMed ID: 18440598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pharmaceutical products in the environment - the "problem" in perspective.
    Taylor D; Senac T
    Chemosphere; 2014 Nov; 115():95-9. PubMed ID: 24525259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC-MS analysis in the aquatic environment and in water treatment technology--a critical review. Part II: Applications for emerging contaminants and related pollutants, microorganisms and humic acids.
    Zwiener C; Frimmel FH
    Anal Bioanal Chem; 2004 Feb; 378(4):862-74. PubMed ID: 14673565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.